Supporting the sustainable design and build of facilities that produce life-improving and life- saving medicines and therapies.
By partnering with clients we support the design, construction and commissioning of best-in-class manufacturing and research facilities to ensure vital drugs, therapies, and products get to market quickly, safely and efficiently.
Our teams engineer flexible, sustainable and future-focused facilities, leveraging decades of experience and industry innovation to deliver complex programmes from start to finish, to time and cost.
With our clients in the pharmaceutical, biotechnology, novel therapies, and medical device sectors, our industry-leading subject matter experts offer solutions for GMP-regulated environments. Our teams can provide environmental services, feasibility studies, process architecture and engineering, Commissioning, Qualification, and Validation (CQV), and everything in between.
Offering personalized services that provide local expertise on a global scale, our comprehensive problem-solving approach ensures that we can identify, design, and deliver the most effective route to the desired endpoint, no matter how complex the project.
Our sectors
Pharmaceutical
We design and develop small molecule and traditional drug manufacturing facilities, supporting adaptation to regulatory changes and operational risk environments.
Biopharmaceutical
Designing and building manufacturing facilities for small-and large-scale biologics. Our areas of expertise include bulk biologics, vaccines, plasma proteins, and industrial fermentation.
Novel therapies
Embedding agility and innovation into facility design for the production of advanced therapy medicinal products (ATMPs).
Cell Therapy
Supporting scaled production of autologous and allogeneic cell therapies including, ‘CAR-T’, iPSC, and other new and emerging cellular derived products.
Gene Therapy
Meeting the regulatory and containment challenges of evolving viral-based platforms, including viral vectors for cell and gene therapies, oncolytic viruses, and viral vector vaccine therapeutics.
mRNA Vaccines
Developing capacity for the clinical and commercial pipeline of RNA-based vaccines and other therapeutics.
Microbiome Therapy
Meeting growing demand for manufacturing capacity in the development of live biotherapeutic products (LBPs).
Oligonucleotides
Combining small-molecule and large-molecule biologic manufacturing process unit operations, accounting for synthetic chemistry and purification processes, aseptic drug product formulation and filling process design. Development and design of solutions in the handling and disposal of large-volume solvents.
Exosome Therapeutics
Manufacturing process and facility design to support the scaled-up development of therapeutic exosomes.
How we help clients
Our teams provide a blend of services designed to meet the needs of your project, including process simulation and optimization, facility retrofits, new product introductions, aging facility rejuvenation, greenfield and brownfield design. We offer unique expertise in process architecture and process engineering, procurement, construction management, consultancy, and professional outsourcing in the US and Europe.
Our Services include:
- Process architecture and process engineering
- Commissioning, qualification, and validation (CQV)
- Construction management
- Strategic consulting
- Product stewardship and environmental services
- Decarbonization
- Managed services
- Technical Services (US)
- Contract Services (EU)
Talk to our experts
Get in touch with Gerry Hamill for more information
Connect with Martijn Karrenbeld for more information & questions.
Solutions
Explore our Life Sciences solutions and discover how we could support you on your journey.
Projects
Find out how we work with our clients around the world to solve everyday challenges and help them achieve business goals.
OUR PARTNERSHIPS
Mission Zero
We are committed to helping our clients achieve their net zero goals. Learn more about Mission Zero, created to help organizations accelerate industrial decarbonization on a global scale.
Talk to our experts
Get in touch with Gerry Hamill for more information